Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Optimer Pharmaceuticals Inc OPTR

Healthcare Biotechnology

Recent & Breaking News (NDAQ:OPTR)

Stellar Biotechnologies Appoints Tessie Che, Ph.D. to Board of Directors

Marketwired September 25, 2013

SHAREHOLDER ALERT: Law Firm Brower Piven Announces That a Class Action Lawsuit Has Been Filed in Connection With the Optimer Pharmaceuticals, Inc. Proposed Buyout Alleging That Optimer's Directors Have Breached Their Fiduciary Duties to Shareholders -- OPTR

Globe Newswire August 14, 2013

Harwood Feffer LLP Announces Investigation of Optimer Pharmaceuticals, Inc.

PR Newswire August 12, 2013

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Optimer Pharmaceuticals, Inc.

Business Wire August 12, 2013

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Optimer Pharmaceuticals, Inc. - OPTR

PR Newswire August 5, 2013

Optimer Pharmaceuticals, Inc. (OPTR) Investor Lawsuit to Halt Takeover Announced by Shareholders Foundation

Globe Newswire August 5, 2013

Investigations into Proposed Buyouts of Optimer Pharmaceuticals, Inc., Trius Therapeutics, Inc. and Maidenform Brands, Inc. Announced by Holzer Holzer & Fistel, LLC

Business Wire August 1, 2013

OPTIMER PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Optimer Pharmaceuticals, Inc. in Connection with Sale of Company to Cubist Pharmaceuticals, Inc.

PR Newswire August 1, 2013

Ryan & Maniskas, LLP Announces Investigation of Optimer Pharmaceuticals, Inc.

PR Newswire August 1, 2013

Strategy Behind Our Success, We Get in Early: RAD, MCP, FCX and OPTR

Marketwired August 1, 2013

Faruqi & Faruqi, LLP, Partner Juan E. Monteverde Launches an Investigation of Optimer Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Cubist Pharmaceuticals, Inc.

Business Wire August 1, 2013

Optimer Reports Second Quarter 2013 Financial Results

PR Newswire August 1, 2013

OPTIMER PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Optimer Pharmaceuticals, Inc. Following Announcement of Proposed Sale of Company to Cubist Pharmaceuticals, Inc.

Business Wire July 31, 2013

OPTIMER PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Optimer Pharmaceuticals, Inc. in Connection with Sale of Company to Cubist Pharmaceuticals, Inc.

Business Wire July 31, 2013

Milberg Announces Investigation of Unfair Low Price In Cubist's Acquisition of Optimer

Business Wire July 31, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Optimer Pharmaceuticals, Inc. - OPTR

PR Newswire July 31, 2013

Rigrodsky & Long, P.A. Announces Investigation Of Optimer Pharmaceuticals, Inc. Buyout

Business Wire July 31, 2013

Finkelstein Thompson LLP Announces Investigation of Optimer Pharmaceuticals, Inc. Buyout

Business Wire July 31, 2013

Optimer Shareholder Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate Sale of Optimer to Cubist

Business Wire July 31, 2013

Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Optimer Pharmaceuticals Proposed Acquisition by Cubist Pharmaceuticals, Inc.

Business Wire July 31, 2013